Seminars in Nephrology
Volume 24, Issue 2 , Pages 168-175, March 2004

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues

  • Amy J Mangrum

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Virginia, Charlottesville, VA, USA
    • ,
  • George L Bakris

      Affiliations

    • Department of Preventive Medicine, Rush Hypertension/Clinical Research Center, Chicago, IL, USA
    • Corresponding Author InformationAddress reprint requests to George Bakris, MD, Rush Medical College, 1700 W. Van Buren St., Suite 470, Chicago, IL 60612 USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0270-9295(03)00191-8

doi:10.1016/j.semnephrol.2003.11.001

Seminars in Nephrology
Volume 24, Issue 2 , Pages 168-175, March 2004

Article Tools